Home›Companies›Biotech & Pharma›Panacent Bio

Panacent Bio Inc.

Updated Oct 27, 2026·Latest SEC filing Jul 12, 2024·Suggest an edit

About Panacent Bio

Panacent Bio is a private company based in New York, New York, incorporated in 2023 in Delaware. It has reported $13 raised in one offering on Form D since July 2024. Its chief executive is Robert Sebra.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 25, 2024Jul 12, 2024$13fully sold1$13EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Panacent Bio's Form D filed Jul 12, 2024.

RS
Robert Sebra
CEO and director
DC
Daniel Charytonowicz
Executive officer

Sources

  1. SECPanacent Bio Inc. filing history